Exosomes as immune regulators in head and neck cancer
Exosomes, virus-sized nanovesicles, are utilized as messenger systems of our body to communicate with other body cells and regulate immune functions. Almost all cells produce exosomes and are able to interact with immune cells in the blood stream and peripheral body areas. Different markers on the surface of exosomes are necessary for immune cell adhesion and interaction. Furthermore, many types of exosome-immune cell interaction, such as surface receptor contact and phagocytosis, are known. As carriers of different cargos, exosomes affect different immune cell types in head and neck cancers: So far, T cells, natural killer cells, macrophages, and dendritic cells have been described in this context. For diagnostic purposes, a combined analysis of different parameters including protein amount, nucleic acid/protein expression, and the immunosuppressive impact of exosomes could empower exosomes as useful tools for evaluation of tumor promotion and progression in the future.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:68 |
---|---|
Enthalten in: |
HNO - 68(2020), 10 vom: 12. Okt., Seite 719-725 |
Sprache: |
Deutsch |
---|
Weiterer Titel: |
Exosomen als Immunregulatoren in Kopf-Hals-Karzinomen |
---|
Beteiligte Personen: |
Ludwig, S [VerfasserIn] |
---|
Links: |
---|
Themen: |
Biomarker |
---|
Anmerkungen: |
Date Completed 28.09.2020 Date Revised 28.09.2020 published: Print Citation Status MEDLINE |
---|
doi: |
10.1007/s00106-020-00871-8 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM309826640 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM309826640 | ||
003 | DE-627 | ||
005 | 20231225134750.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||ger c | ||
024 | 7 | |a 10.1007/s00106-020-00871-8 |2 doi | |
028 | 5 | 2 | |a pubmed24n1032.xml |
035 | |a (DE-627)NLM309826640 | ||
035 | |a (NLM)32399644 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a ger | ||
100 | 1 | |a Ludwig, S |e verfasserin |4 aut | |
245 | 1 | 0 | |a Exosomes as immune regulators in head and neck cancer |
246 | 3 | 3 | |a Exosomen als Immunregulatoren in Kopf-Hals-Karzinomen |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 28.09.2020 | ||
500 | |a Date Revised 28.09.2020 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Exosomes, virus-sized nanovesicles, are utilized as messenger systems of our body to communicate with other body cells and regulate immune functions. Almost all cells produce exosomes and are able to interact with immune cells in the blood stream and peripheral body areas. Different markers on the surface of exosomes are necessary for immune cell adhesion and interaction. Furthermore, many types of exosome-immune cell interaction, such as surface receptor contact and phagocytosis, are known. As carriers of different cargos, exosomes affect different immune cell types in head and neck cancers: So far, T cells, natural killer cells, macrophages, and dendritic cells have been described in this context. For diagnostic purposes, a combined analysis of different parameters including protein amount, nucleic acid/protein expression, and the immunosuppressive impact of exosomes could empower exosomes as useful tools for evaluation of tumor promotion and progression in the future | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Biomarker | |
650 | 4 | |a Cell-mediated immunity | |
650 | 4 | |a Extracellular vesicles (EV) | |
650 | 4 | |a Immunotherapy | |
650 | 4 | |a Lymphocyte | |
700 | 1 | |a Rotter, N |e verfasserin |4 aut | |
700 | 1 | |a Theodoraki, M-N |e verfasserin |4 aut | |
700 | 1 | |a Jablonska, J |e verfasserin |4 aut | |
700 | 1 | |a Lammert, A |e verfasserin |4 aut | |
700 | 1 | |a Lang, S |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t HNO |d 1948 |g 68(2020), 10 vom: 12. Okt., Seite 719-725 |w (DE-627)NLM000004588 |x 1433-0458 |7 nnns |
773 | 1 | 8 | |g volume:68 |g year:2020 |g number:10 |g day:12 |g month:10 |g pages:719-725 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00106-020-00871-8 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 68 |j 2020 |e 10 |b 12 |c 10 |h 719-725 |